Skip to content
Open access

Transdiagnostic metacognitive therapy compared to disorder-specific cognitive behavioral therapy for anxiety disorders: a study protocol for a randomized controlled superiority trial

Oct 2026 · Trials · Vol 27 · 0 citations · 80 references
Medicine

Abstract

Anxiety disorders are highly prevalent worldwide and are associated with functional impairment, reduced quality of life and high societal costs. With only approximately 50% of patients achieving remission following cognitive behavioral therapy (CBT), the evaluation of other effective treatments is warranted. Studies suggest that metacognitive therapy (MCT) may be more effective than CBT for anxiety disorders. Although transdiagnostic treatment may be beneficial for treatment implementation and dissemination in routine care, there is currently only one adequately powered study comparing transdiagnostic MCT (tMCT) to disorder-specific CBT for anxiety disorders. The main aim of this trial is to investigate the effectiveness of tMCT compared to disorder-specific CBT for anxiety disorders. The trial also aims to investigate potential mediators of treatment effects in tMCT and CBT, to conduct a health economic evaluation and to explore patients' perspectives on the treatments. This trial is a prospective, pragmatic, two-arm parallel-group randomized controlled superiority trial comparing tMCT with disorder-specific CBT, conducted in outpatient psychiatric services in Stockholm, Sweden. A sample of 86 adults with a principal diagnosis of generalized anxiety disorder, social anxiety disorder or posttraumatic stress disorder will be recruited and randomly allocated to tMCT or CBT. Primary outcomes are self-rated symptoms of principal diagnosis, and secondary outcomes are clinical severity, remission rates, depressive symptoms, functional impairment and quality of life. Outcomes will be assessed at pre- and post-treatment as well as at 6- and 12-month follow-up. Metacognitions and cognitions as potential mediators will be measured weekly during treatment. Cost-effectiveness of tMCT compared to CBT will be investigated. Semi-structured interviews will be conducted with participants from both conditions. Considering the potential of MCT, further research is needed to evaluate its effectiveness compared to CBT, particularly MCT in a transdiagnostic format. Results from this trial will add to the evidence base for tMCT and inform treatment development, decision-making and implementation of effective treatment for anxiety disorders in routine care. ClinicalTrials.gov NCT06937892. Registered on April 22nd, 2025

Read PDF

Similar papers

Review Open access Oct 2026

Comparative Efficacy and Acceptability of Transdiagnostic Psychotherapies for Emotional Disorders: Protocol for a Network Meta-Analysis of Randomized Controlled Trials

Background Emotional disorders—primarily anxiety and unipolar depressive disorders—are highly prevalent, disabling, and frequently comorbid. Disorder‑specific cognitive behavioral therapy (DS‑CBT) is considered a gold standard treatment, yet it can be inefficient in the context of high comorbidity and service constrain...

Qiao-Si Cai, Yi-Han Zeng, Noelia Jiménez-Orenga et al. · 0 citations
Review Open access Sep 2026

Intensive cognitive behavioral therapy for obsessive-compulsive disorder: a meta-analysis of randomized controlled trials

Background Intensive cognitive behavioral therapy (CBT) delivers more or longer sessions over a shorter time than standard CBT. This review aimed to examine the effects of intensive CBT in comparison to non-active conditions and other active treatments for obsessive-compulsive disorder (OCD). Method We analyzed standar...

Jian-Li Zhu, Chun-Xiao Zhang, Xin-Peng Xu et al. · 0 citations
Open access Sep 2026

Effectiveness of cognitive behavioural therapy on anxiety and depression symptoms in naturalistic settings for patients with and without personality disorders.

OBJECTIVES Personality disorders (PD) are often considered a negative prognostic factor for cognitive behavioural therapy (CBT) in anxiety and depression, yet evidence from real-world settings with rigorous diagnostic assessment remains limited. This study examined whether PD diagnosis influences CBT outcomes using dat...

G. Caselli, Silvia Grazioli, Rossana Piron et al. · 0 citations
Open access Sep 2026

Efficacy of a personalized, response-based transdiagnostic intervention for emotional disorders delivered via the Internet: a protocol for an adaptive randomized controlled trial

One of the main challenges in clinical psychotherapy is disseminating effective psychological treatments to the millions who need them but lack access. Transdiagnostic interventions, particularly those delivered online, can help bridge this treatment gap. However, these interventions, often provided as a “one-size-fits...

Fernanda Longo Elia, A. García-Palacios, Cristina Botella et al. · 0 citations
Sep 2026

Investigating Potential Mechanisms of Change Within Community Mental Health Treatment for Adolescent Emotional Disorders.

OBJECTIVE Single domain cognitive-behavioral therapy (CBT) protocols for adolescents with anxiety or depression demonstrate strong efficacy in clinical trials but poorer effectiveness in community settings. Transdiagnostic CBT targeting core dysfunctions shared across emotional disorders may address barriers to treatme...

Lauren Milgram, A. Jensen-Doss, David Rosenfield et al. · 0 citations
Review Open access Sep 2026

CBT and pharmacotherapy after nonresponse for anxiety and obsessive-compulsive disorders in youth: a systematic review and meta-analysis

Approximately half of children with anxiety disorder(s) or obsessive-compulsive disorder (OCD) derive insufficient benefit from first-step evidence-based treatments, including cognitive behavioural therapy (CBT) and pharmacotherapy. Few studies have examined second-step treatment options, and clinical guidelines offer...

Colin O. W. Ganzevoort, Rianne Hornstra, L. Wolters et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.